GT Biopharma, Inc. (GTBP)
0.299
-0.01
(-2.22%)
USD |
NASDAQ |
Aug 25, 16:00
0.299
0.00 (0.00%)
After-Hours: 17:13
GT Biopharma 1 Year Total Returns (Daily) : -72.45% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | -72.45% |
| August 21, 2026 | -73.03% |
| August 20, 2026 | -73.89% |
| August 19, 2026 | -78.43% |
| August 18, 2026 | -81.45% |
| August 17, 2026 | -78.73% |
| August 14, 2026 | -79.59% |
| August 13, 2026 | -82.30% |
| August 12, 2026 | -82.73% |
| August 11, 2026 | -82.02% |
| August 10, 2026 | -82.09% |
| August 07, 2026 | -82.51% |
| August 06, 2026 | -82.70% |
| August 05, 2026 | -82.06% |
| August 04, 2026 | -81.68% |
| August 03, 2026 | -82.95% |
| July 31, 2026 | -84.22% |
| July 30, 2026 | -84.61% |
| July 29, 2026 | -85.21% |
| July 28, 2026 | -84.92% |
| July 27, 2026 | -83.78% |
| July 24, 2026 | -84.85% |
| July 23, 2026 | -84.19% |
| July 22, 2026 | -82.59% |
| July 21, 2026 | -82.26% |
| Date | Value |
|---|---|
| July 20, 2026 | -83.45% |
| July 17, 2026 | -82.47% |
| July 16, 2026 | -81.20% |
| July 15, 2026 | -82.48% |
| July 14, 2026 | -82.76% |
| July 13, 2026 | -82.61% |
| July 10, 2026 | -81.44% |
| July 09, 2026 | -79.00% |
| July 08, 2026 | -77.19% |
| July 07, 2026 | -78.80% |
| July 06, 2026 | -82.48% |
| July 02, 2026 | -84.76% |
| July 01, 2026 | -85.47% |
| June 30, 2026 | -86.32% |
| June 29, 2026 | -87.57% |
| June 26, 2026 | -88.68% |
| June 25, 2026 | -87.62% |
| June 24, 2026 | -86.26% |
| June 23, 2026 | -84.62% |
| June 22, 2026 | -83.92% |
| June 18, 2026 | -82.52% |
| June 17, 2026 | -83.61% |
| June 16, 2026 | -84.20% |
| June 15, 2026 | -83.50% |
| June 12, 2026 | -84.15% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 15.19% |
| Alnylam Pharmaceuticals, Inc. | -48.06% |
| Anika Therapeutics, Inc. | 121.1% |
| Savara, Inc. | 75.95% |
| Vericel Corp. | 14.23% |